Concepedia

Mervyn Israel

MI

Statistics

Publications

84

Citations

2.8K

H-Index

29

Active since

1959

Affiliations

University of Tennessee Health Science Center(Current)

Harvard University

National Foundation for Cancer Research

University of Memphis

Cancer Research Foundation

Mervyn Israel is an author at University of Tennessee Health Science Center specializing in pharmacology, chemotherapy, and medicine.

Publications per year

1959–2007

84

Publications

84

DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.

Annette L. Bodley, Leroy F. Liu, Mervyn Israel et al. · PubMed · 1989 · 230 citations

Medicine, Medicinal Chemistry, Pharmacology +15

N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.

Mervyn Israel, Edward J. Modest, Emil Frei · PubMed · 1975 · 129 citations

Medicine, Oncology, Pharmacology +13

ATM and the Catalytic Subunit of DNA-Dependent Protein Kinase Activate NF-κB through a Common MEK/Extracellular Signal-Regulated Kinase/p90<sup><i>rsk</i></sup> Signaling Pathway in Response to Distinct Forms of DNA Damage

Ganesh R. Panta, Swayamjot Kaur, Lakita G. Cavin et al. · Molecular and Cellular Biology · 2004 · 126 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological Fluids

Mervyn Israel, William J. Pegg, P M Wilkinson et al. · Journal of Liquid Chromatography · 1978 · 119 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +11

A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin.

Marc B. Garnick, William D. Ensminger, Mervyn Israel · PubMed · 1979 · 77 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +11

1–5 of 84